Colorectal, Cancer Clinical Trials in Stanford, California
4 recruitingStanford, California
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Colorectal, CancerOvarian CancerLung Cancer+17 more
A2 Biotherapeutics Inc.474 enrolled12 locationsNCT06051695
Recruiting
Phase 1Phase 2
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Colorectal, CancerNon-small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.534 enrolled53 locationsNCT06128551
Recruiting
Phase 1Phase 2
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Colorectal, CancerEsophageal CancerPancreatic Cancer+3 more
Lantheus Medical Imaging26 enrolled5 locationsNCT06298916
Recruiting
Phase 1
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Triple-Negative Breast CancerColorectal, CancerGastric Cancer+6 more
BioEclipse Therapeutics60 enrolled3 locationsNCT04282044